01/14/2021 7:47 PM
Clarín.com
Society
Updated on 01/14/2021 20:03
Argentina surpassed 45,000 deaths from coronavirus this Thursday, only ten months after registering the first death from this disease.
This is reflected in the new daily part of the Ministry of Health of the Nation, which reported
another 142 fatalities and 13,286 new positive cases
.
Since the beginning of the pandemic, the country has added 45,125 deaths and 1,770,715 infections.
Globally, Argentina ranks twelfth in number of infected - only surpassed in the region by Brazil and Colombia - and ranks 13th in number of victims.
Of the last reported deaths (86 men, 53 women and three people whose sex was not reported), 55 resided in the province of Buenos Aires, 19 in Santa Fe, 15 in Córdoba, 12 in Chubut, ten in Río Negro;
seven in Misiones and Mendoza;
six in the City of Buenos Aires (CABA), three in Santa Cruz, Tierra del Fuego and Chaco;
two in Entre Ríos and one in San Juan and San Luis.
In the last 24 hours, 50,729 tests were carried out, with a
positivity of 26.1%
.
Since the beginning of the outbreak, 5,415,971 diagnostic tests for this disease have been performed, which is equivalent to 119,355 samples per million inhabitants.
Of the 176,100 people who are experiencing the disease, 3,634 remain hospitalized in Intensive Care Units (ICU).
Occupancy in this sector is 59.9% in the Metropolitan Area of Buenos Aires (AMBA) and 55.2% in the rest of the country.
Situation # COVID19 in Argentina
Confirmed: 13,286 |
Total: 1,770,715 Deaths
: 142 |
Total: 45,125
ICU beds occupancy: 3,634
Percentage of total adult ICU beds occupancy:
- Nation: 55.2%
- AMBA: 59.9%
Full report: https://t.co/W4G970nscs pic.twitter.com/WDJwEbZ3m3
- Ministry of Health of the Nation (@msalnacion) January 14, 2021
Meanwhile, the Government again warned that "in the last month,
cases began to rise throughout the country
, especially in the City and the province of Buenos Aires, with different behavior from infections in people between 30 and 50 years ".
In that sense, the Chief of Staff, Santiago Cafiero, spoke of the "challenge" of managing the pandemic seeking to find "a balance between the restrictions" to prevent infections "
without affecting economic activity."
At this stage, that bridge must be found until the vaccination campaign begins to have the effects of immunization, "the official said at a videoconference press conference organized by the Association of Journalists of the Argentine Republic (Apera).
On the other hand, a study carried out by researchers from the Leloir and Conicet Institute specified that 95% of the patients who had Covid-19 developed antibodies 45 days after having started with symptoms;
more than 90% after the third week and 35% after seven days.
The results arise from the analysis of more than 3,000 samples from infected people in the country with severe, mild and asymptomatic manifestations studied with the COVIDAR IgG and IgM serological tests.
This is how they perform swabs at the Dellepiane bus terminal, in the City of Buenos Aires.
Andrea Gamarnik, director of the study, head of the FIL Molecular Virology Laboratory and senior researcher at Conicet, described that "there are different types of antibodies; a part of them are those that have protective or 'neutralizing' effects because they prevent the virus from infect the cell; the presence of these antibodies -which are IgG- could prevent reinfections and would be those that have therapeutic power in convalescent plasmas ".
The research reached several conclusions: when measuring the levels of IgG and IgM antibodies over time in 100 infected individuals, it was observed that "in most cases the appearance of the two antibodies occurs simultaneously".
"This is one of the things we learned about the new coronavirus and that it is different from other infections in which IgMs appear first and then IgGs," said Beatriz Perazzi, also an author of the study, teacher and deputy director of the Department of Clinical Biochemistry of the Faculty of Pharmacy and Biochemistry.
And he continued: "In addition, in the first three months of the infection we saw that the levels of antibodies persisted high."
News in development